Evoke Announces Teva Ends Pursuit of Paragraph IV ANDA
FDA Approval Letter - Teva Pharmaceuticals
New York Opioid Trial: Allergan Settlement Leaves Teva as Last Target - Bloomberg
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva Holds off Huntington's Competitor, Resolves Opioid Cases | BioSpace
Allergan sells Anda to Teva for $500 million - CDR – Chain Drug Review
Generics distributor Anda, Inc. has a new owner: Teva Pharma
AXSM stock slips as Teva seeks generic for depression therapy (NASDAQ:AXSM) | Seeking Alpha
Teva Completes Acquisition of Anda Inc | World Pharma Today
Who We Are | AndaNet
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
Teva wants Allergan's distribution biz now that $40B drug deal has closed | Fierce Pharma
Teva Pharmaceuticals Found Liable in Landmark Opioid Trial - The New York Times
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals USA and Anda, Inc.... - Kids In Distress | Facebook
FDA Priority ANDA Review and Teva api support | Teva api
Teva Pharmaceutical Industries (NYSE: TEVA) Q4 2019 Earnings | AlphaStreet
Teva: Dr. Reddy's buys eight ANDAs from Teva for $350 million - The Economic Times
Rosiglitazone Maleate and Glimepiride Tablets, 4 mg (base)/1 mg, 4 mg (base)/2 mg, 4 mg (base)/4 mg, 8 mg (base)/2 mg, and 8 mg
Teva to Buy Generics Distributor Anda From Allergan for $500 Million - WSJ
Teva Takes Aim At First Truvada And Atripla Generics In US :: Generics Bulletin
Teva completes $40.5B Actavis deal, agrees to buy Anda for $500M - Philadelphia Business Journal
